bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Hemab Therapeutics Inc. Common Stock logo

    Hemab Therapeutics Inc. Common Stock

    COAG | NASDAQ
    Chart Builder DCF Calculator
    $41.91
    +$0.46 (+1.11%)
    Nov 2, 2026, 9:57 AM ET · Market open
    Income Statement Balance Sheet Cashflow Statement Ratios
    Annual Quarterly TTM

    Revenue

    High 0 Q1 2026
    Low 0 Q1 2026
    Fiscal Quarter
    Period Ending
    Q2 2026
    Jun 30, 2026
    Q1 2026
    Mar 31, 2026
    Revenue
    		n/a n/a
    Cost of Revenue
    		75K n/a
    Gross Profit
    		-75K n/a
    Operating Income
    		-26.08M -23.61M
    Interest Income
    		2.86M 1.22M
    Pretax Income
    		-24.05M -22.68M
    Net Income
    		-24.15M -22.69M
    Selling & General & Admin
    		5.74M 4.15M
    Research & Development
    		20.34M 19.46M
    Other Expenses
    		n/a n/a
    Operating Expenses
    		26.08M 23.61M
    Interest Expense
    		n/a n/a
    Selling & Marketing Expenses
    		n/a n/a
    Cost & Expenses
    		26.08M 23.61M
    Income Tax Expense
    		97K 12K
    Shares Outstanding (Basic)
    		30.11M 44.19M
    Shares Outstanding (Diluted)
    		30.11M 44.19M
    EPS (Basic)
    		-0.80 -0.51
    EPS (Diluted)
    		-0.80 -0.51
    EBITDA
    		-26.01M -23.54M
    EBIT
    		-26.08M -23.61M
    Depreciation & Amortization
    		73K 73K

    © 2026 bestshares.com. All rights reserved.

    All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.